Evaluation of the novel gene Rabl3 in the regulation of proliferation and motility in human cancer cells

Oncology Reports

Volumn 24, Issue 2, 2010, Pages 433-440

  Li, Qi ^a,b   Wang, Li ^a,b   Zeng, Linge ^a,b   Zhang, Yingmei ^a,b   Li, Kangqi ^a,b   Jin, Peng ^a,b   Su, Bingnan ^a   Wang, Lu ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Apoptosis; Focal adhesion kinase; Motility; Paclitaxel; Rab

Indexed keywords

DNA; FOCAL ADHESION KINASE; PACLITAXEL; PLASMID DNA; PROTEIN RABL3; RAB PROTEIN; SMALL INTERFERING RNA; TYROSINE; UNCLASSIFIED DRUG; RAB-LIKE 3 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER THERAPY; CARCINOGENESIS; CELL FUNCTION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE CONTROL; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; METASTASIS; ONCOGENE; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; AMINO ACID SEQUENCE; CELL MOTION; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; HELA CELL LINE; HL 60 CELL LINE; HT 29 CELL LINE; K562 CELL LINE; MOLECULAR GENETICS; NEOPLASM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYLOGENY; TUMOR CELL CULTURE;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL MOVEMENT; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HL-60 CELLS; HT29 CELLS; HUMANS; K562 CELLS; MOLECULAR SEQUENCE DATA; NEOPLASMS; PACLITAXEL; PHYLOGENY; RAB GTP-BINDING PROTEINS; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 77954366653     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000876     Document Type: Article

References (27)

1. Yang H, Sasaki T, Minoshima S and Shimizu N: Identification of three novel proteins (SGSM1, 2, 3) which modulate small G protein (RAP and RAB)-mediated signaling pathway. Genomics 90: 249-260, 2007.
2. Ramos FP, Araripe JR, Ürményi TP, Silva O, Silva NLC, Fontes CFL, Silveira JF and Rondinelli E: Characterization of RAB-like4, the first identified RAB-like protein from Trypanosoma cruzi with GTPase activity. Biochem Biophys Res Commun 333: 808-817, 2005.
3. Hagiwara M, Shirai Y, Nomura R, Sasaki M, Kobayashi K, Tadokoro T and YamamotoY: Caveolin-1 activates Rab5 and enhances endocytosis through direct interaction. Biochem Biophys Res Commun 378: 73-78, 2009.
4. Deneka M, Neeft M and Van der Sluijs P: Regulation of membrane transport by Rab GTPases. Crit Rev Biochem Mol Biol 38: 121-142, 2003. (Pubitemid 36575480)
5. Dong C and Wu G: Regulation of anterograde transport of adrenergic and angiotensin II receptors by Rab2 and Rab6 GTPases. Cell Signal 19: 2388-2399, 2007.
6. Bizimungu C and Vandenbo M: At least two regions of the oncoprotein Tre2 are involved in its lack of GAP activity. Biochem Biophys Res Commun 335: 883-890, 2005.
7. Shan J, Mason JM, Yuan LM, Barcia M, Calabro DP, Budman D, Vinciguerra V and Xu HP: Rab6c, a new member of the Rab gene family, is involved in drug resistance in MCF7/AdrR cells. Gene 257: 67-75, 2000.
8. Weaver V and Werb Z: G'rab'bing the microenvironment for invasion. Dev Cell 13: 462-463, 2007.
9. Caswell PT, Spence HJ, Parsons M,White DP, Clark K, Cheng KW, Mills GB, Humphries MJ, MessentA J, Anderson KI, McCaffrey MW, Ozanne BW and Norman JC: Rab25 Associates with a5b1 integrin to promote invasive migration in 3D microenvironments. Dev Cell 13: 496-510, 2007.
10. Cheng KW, Lu YL and Mills GB: Assay of Rab25 function in ovarian and breast cancers. Methods Enzymol 403: 202-215, 2005.
11. Amillet JM, Ferbus D, Real F X, Antony C, Muleris M, Gress TM and Goubin G: Characterization of human Rab20 overexpressed in exocrine pancreatic carcinoma. Human Pathol 37: 256-263, 2006.
12. Tito NN, Robledo T and Salazar EP: Arachidonic acid promotes FAK activation and migration in MDA-MB-231 breast cancer cells. Exp Cell Res 314: 3340-3355, 2008.
13. Fong YC, Liu SC, Huang CY, Li TM, Hsu SF, Kao ST, Tsai FJ, Chen WC, Chen CY and Tang CH: Osteopontin increases lung cancer cells migration via activation of the αvβ3 integrin/FAK/Akt and NF-κB-dependent pathway. J Lung Cancer 64: 263-270, 2008.
14. Gilmore AP and Romer LH: Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol Biol Cell 7: 1209-1124, 1996.
15. Lin AH, Eliceiri BP and Levin EG: FAK mediates the inhibition of glioma cell migration by truncated 24 kDa FGF-2. Biochem Biophys Res Commun 382: 503-507, 2009.
16. Baillat G, Siret C, Delamarre E and Luis J: Early adhesion induces interaction of FAK and Fyn in lipid domains and activates raft-dependent Akt signaling in SW480 colon cancer cells. Biochim Biophys Acta 1783: 2323-2331, 2008.
17. Marupudi NI, Han JE, Li KW, Renard VM, Tyler BM and Brem H: Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opinion Drug Saf 6: 609-621, 2007.
18. Chen TS, Wang XP, Sun L, Wang LX, Xing D and Mok M: Taxol induces caspase-independent cytoplasmic vacuolization and cell death through endoplasmic reticulum (ER) swelling in ASTC-a-1 cells. Cancer Lett 270: 164-172, 2008.
19. Schiff PB, Fant J and Horwitz SB: Promotion of microtubule assembly in vitro by taxol. Nature 277: 665-667, 1979. (Pubitemid 9114288)
20. Ahmed AA, Mills AD, Ibrahim AEK, Temple J, Blenkiron C, Vias M, Massie CE, Iyer NG, McGeoch A, Crawford R, Nicke B, Downward J, Swanton C, Bell SD, Earl HM, Laskey RA, Caldas C and Brenton JD: The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel. Cancer Cell 12: 514-527, 2007.
21. Michele MD, Corte AD, Cicchillitti L, Boccio PD, Urbani A, Ferlini C, Scambia G, Donati MB and Rotilio D: A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines. Biochim Biophys Acta 1794: 225-236, 2009.
22. Yu CF, Han WL, Shi TP, Lv BF, He QH, Zhang YF, Li T, Zhang YM, Song QS, Wang L and Ma DL: PTPIP51, a novel 14-3-3 binding protein, regulates cell morphology and motility via Raf-ERK pathway. Cell Signal 20: 2208-2220, 2008.
23. Luchetti F, Betti M, Canonico B, Arcangeletti M, Ferri P, Galli F and Papa S: ERK MAPK activation mediates the anti-apoptotic signaling of melatonin in UVB-stressed U937 cells. Free Radic Biol Med 46: 339-351, 2009.
24. Huisman C, Ferreira CG, Broker LE, Rodriguez JA, Smit EF, Postmus PE, Kruyt FAE and Giaccone G: Paclitaxel triggers cell death primarily via caspase independent routes in the nonsmall cell lung cancer cell line NCI-H4601. Clin Cancer Res 596: 596-606, 2002.
25. Selimovic D, Hassan M, Haikel Y and Hengge UR: Taxol-induced mitochondrial stress in melanoma cells is mediated by activation of c-Jun N-terminal kinase (JNK) and p38 pathways via uncoupling protein 2. Cell Signal 20: 311-322, 2008.
26. Hsiu K, Lue KH, Liao HH, Lin KL and Chung JG: Induction of caspase-3-dependent apoptosis in human leukemia HL-60 cells by paclitaxel. Clin Chim Acta 357: 65-73, 2005.
27. Berndtsson M, Konishi Y, Bonni A, Hagg M, Shoshan M, Linder S and Havelka AM: Phosphorylation of BAD at Ser-128 during mitosis and paclitaxel-induced apoptosis. FEBS Lett 579: 3090-3094, 2005.